atorvastatin has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Mistafa, O; Roudier, E; Stenius, U | 1 |
| Cheng, L; Shen, L; Wang, Q; Wu, Z; Zhang, L; Zhou, D; Zhu, J | 1 |
| Che, XY; Han, F; He, B; Jiang, LS; Peng, S; Shao, Q; Xiao, QQ | 1 |
4 other study(ies) available for atorvastatin and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Carcinoma, Hepatocellular; Cell Proliferation; Chromones; Dose-Response Relationship, Drug; Etoposide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Neoplasms; Morpholines; Phosphorylation; Pravastatin; Protein Kinases; Proto-Oncogene Proteins c-akt; Pyrroles; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2006 |
Atorvastatin protects cardiomyocytes from oxidative stress by inhibiting LOX-1 expression and cardiomyocyte apoptosis.
Topics: Animals; Apoptosis; Atorvastatin; Caspase 3; Caspase 9; Cell Line; Cell Survival; Chromones; Hydrogen Peroxide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Morpholines; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; RNA, Messenger; Scavenger Receptors, Class E; Signal Transduction | 2015 |
Atorvastatin ameliorates LPS-induced inflammatory response by autophagy via AKT/mTOR signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Autophagy; Autophagy-Related Proteins; Chromones; Gene Expression Regulation; Interleukin-1beta; Lipopolysaccharides; Macrophages; Mice; Morpholines; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2018 |